Results 11 to 20 of about 171,666 (338)
Recent advances in preclinical studies combining hyperthermia therapy with novel immune checkpoint targeting agents [PDF]
Frontiers in ImmunologyHyperthermia has been used as an adjuvant therapy alongside radiotherapy and chemotherapy for cancer treatment in some countries. However, since the 2000s, growing evidence has indicated that hyperthermia exerts regulatory effects not only on cancer ...
Na Li +12 more
doaj +2 more sources
Lancet, The, 1998 SummaryMalignant hyperthermia is a rare autosomal dominant trait that predisposes affected individuals to great danger when exposed to certain anaesthetic triggering agents (such as potent volatile anaesthetics and succinylcholine). A sudden hypermetabolic reaction in skeletal muscle leading to hyperthermia and massive rhabdomyolysis can occur.
R, Ben Abraham +3 more
exaly +5 more sources
Hyperthermia-targeted rectal delivery of thermosensitive liposomal doxorubicin via intra-arterial and intravenous administration [PDF]
Frontiers in PharmacologyIntroductionLyso-thermosensitive liposomal doxorubicin (LTLD) is a thermosensitive nanomedicine designed to release doxorubicin rapidly at mild hyperthermic temperatures.
Andrew S. Mikhail +12 more
doaj +2 more sources
International Journal of Hyperthermia, 2021 Purpose To develop a head and neck hyperthermia phased array system compatible with a 1.5 T magnetic resonance (MR) scanner for noninvasive thermometry.
Tomas Drizdal +7 more
doaj +1 more source
European Journal of Anaesthesiology, 2001 Malignant hyperthermia is an autosomal-dominant inherited disorder of the skeletal muscle cell characterized by a hypermetabolic response to all commonly used inhalational anaesthetics and depolarizing muscle relaxants. The clinical syndrome includes muscle rigidity, hypercapnia, tachycardia and myoglobinuria as result of increased carbon dioxide ...
J K, Kozack, D L, MacIntyre
openaire +5 more sources
Impact of a digital manual for guidance on malignant hyperthermia: patient education
Orphanet Journal of Rare Diseases, 2022 Background Malignant hyperthermia (MH) is a rare, hereditary disease with a hypermetabolic response to volatile anesthetics/succinylcholine. Susceptible patients face difficulties due to a lack of knowledge about MH.
Gislene Rodrigues +4 more
doaj +1 more source
Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge
Children, 2022 Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile anesthetics and succinylcholine. Rarely, MH can occur after non-pharmacological triggers too. MH was detected more often in children and young adults, which
Martina Klincová +4 more
doaj +1 more source
Chinese Medical Journal, 2021 . Background. Hyperthermia in combination with DnaJA4-knockout (KO) obviously affects the anti-viral immunity of HaCaT cells. The mechanisms of this process are not yet fully explored.
Rui-Jiao Liu +6 more
doaj +1 more source
International Journal of Hyperthermia, 2020 Purpose Thermal dose-effect relations have demonstrated that clinical effectiveness of hyperthermia would benefit from more controlled heating of the tumor.
Gennaro G. Bellizzi +7 more
doaj +1 more source
Focused ultrasound restrains the growth of orthotopic colon cancer via promoting pyroptosis
Folia Histochemica et Cytobiologica, 2023 INTRODUCTION: Focused ultrasound (FUS) is a non-invasive tumor therapy technology emerging in recent years, which can treat various solid tumors. However, it is unclear whether FUS can affect the pyroptosis of colon cancer (CC) cells.
Weixing Mo +8 more
doaj +1 more source